KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) EPS (Basic) (2016 - 2026)

Abbott Laboratories' EPS (Basic) history spans 18 years, with the latest figure at $0.62 for Q1 2026.

  • On a quarterly basis, EPS (Basic) fell 18.42% to $0.62 in Q1 2026 year-over-year; TTM through Mar 2026 was $3.59, a 53.5% decrease, with the full-year FY2025 number at $3.73, down 51.37% from a year prior.
  • EPS (Basic) hit $0.62 in Q1 2026 for Abbott Laboratories, down from $1.01 in the prior quarter.
  • Over the last five years, EPS (Basic) for ABT hit a ceiling of $5.28 in Q4 2024 and a floor of $0.59 in Q4 2022.
  • Historically, EPS (Basic) has averaged $1.13 across 5 years, with a median of $0.82 in 2022.
  • Biggest five-year swings in EPS (Basic): soared 473.91% in 2024 and later plummeted 80.87% in 2025.
  • Tracing ABT's EPS (Basic) over 5 years: stood at $0.59 in 2022, then skyrocketed by 55.93% to $0.92 in 2023, then soared by 473.91% to $5.28 in 2024, then plummeted by 80.87% to $1.01 in 2025, then crashed by 38.61% to $0.62 in 2026.
  • Business Quant data shows EPS (Basic) for ABT at $0.62 in Q1 2026, $1.01 in Q4 2025, and $0.94 in Q3 2025.